MFDS
- Marketing authorisation holder: SENTYNL THERAPS INC
- Status: likely_approved
🇰🇷 Arnicare Leg Cramps in South Korea
Arnicare Leg Cramps (COPPER) regulatory status in South Korea.
Marketing authorisation
Arnicare Leg Cramps in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in South Korea
Frequently asked questions
Is Arnicare Leg Cramps approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Arnicare Leg Cramps in South Korea?
SENTYNL THERAPS INC holds the South Korean marketing authorisation.